in

Zydus Lifesciences Signs Exclusive Pact With Synthon BV For Novel Oncology Product

Zydus Lifesciences Ltd. on Wednesday said it has signed an exclusive development, licensing, supply and commercialisation pact with Synthon BV of the Netherlands for a novel oncology product for an undisclosed target.

(Photo source: Zydus Lifesciences website)

Read More

What do you think?

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Torrent Group Acquires Majority Stake In IPL Franchise Gujarat Titans

Misreporting Pesky Calls, Messages To Cost Telcos Fines Up To Rs 10 Lakh